Resources

1. What is the clinical effectiveness of medical cannabis for the treatment of chronic pain?
2. What are the evidence-based guidelines associated with the use of medical cannabis for the treatment of chronic pain?

Cannabinoid Pharmacology: The First 66 Years 
Research into the pharmacology of individual cannabinoids that began in the 1940s, several decades after the presence of a cannabinoid was first detected in cannabis, is concisely reviewed. Also described is how this pharmacological research led to the discovery of cannabinoid CB1 and CB2 receptors and of endogenous ligands for these receptors, to the development of CB1- and CB2-selective agonists and antagonists and to the realization that the endogenous cannabinoid system has significant roles in both health and disease, and that drugs which mimic, augment or block the actions of endogenously released cannabinoids must have important therapeutic applications. Some goals for future research are identified.

• Is it legal for dietary supplements or foods?
• Are Cannabis or cannabinoids helpful in treating health conditions?
• Are cannabis and cannabinoids safe?
• Can CBD be harmful?

• CDA Industrial Hemp Research and Development Program
• Mobile Laboratory
• REACH Research Excellence Award

• Risk and addiction
• If you need help on substance use disorder

SAMHSA’s National Helpline

• SAMHSA’s National Helpline is a free, confidential, 24/7, 365-day-a-year treatment referral and information service (in English and Spanish) for individuals and families facing mental and/or substance use disorders.
  

National Institute of Health - National Cancer Institute

• Cannabis and cannabinoids (PDQ) - Patient Version

• Farm Bill Information
• Crop insurance and safety net
• Reporting hemp acres
• Farm loans

• Certified Seed
• CHAMP Initiative
• Online Portal
• Forms and Reports
• Inspection and testing
• Rules and Regulations
• Pesticides

• Insect Management
• Certified Seed
• CSU and Other Resource

• Regulations of industrial hemp cultivation in Colorado
• Colorado certified seed program
• Industrial Hemp Advisory Committee

• Consumer Information
• FDA Communications
• Regulatory Resources

New Application for Registration- U.S. Department of Justice, Drug Enforcement Administration
Any person who does not currently possess a DEA registration to conduct business with controlled substances. The categories of applicant who can apply using this form are manufacturers, distributors, researchers, canine handlers, analytical laboratories, importers, and exporters

• Patients
• Health care provider
• Parents of minor patients

• MED rules and license
• Application or renewal for employee license 

• Hemp Research
• Marijuana Research
• Colorado Cannabis & Hemp Research Forum

National Institute on Drug Abuse (NIDA) - Cannabis Science Interest (CSI) Group
The CSI Group aims to promote discussion and knowledge dissemination about cutting edge scientific findings as well as changes in policy and legal status of cannabis, in order to generate innovative ideas for NIDA's research portfolio and dissemination/outreach strategies for all audiences.

• Marijuana Concentrates DrugFacts
• Marijuana Research Report
• NIDA's Role in Providing Marijuana for Research

New DEA Licensed Cannabis Sources Available for Research

• Priorities in Natural Products Research
• NCCIH Funding Opportunities

• Marijuana facts and statistics
• CDC Publications about marijuana research and health